[go: up one dir, main page]

GB1405767A - Method formulation and pharmaceutical composition for reducing plasma lipid levels - Google Patents

Method formulation and pharmaceutical composition for reducing plasma lipid levels

Info

Publication number
GB1405767A
GB1405767A GB5783072A GB5783072A GB1405767A GB 1405767 A GB1405767 A GB 1405767A GB 5783072 A GB5783072 A GB 5783072A GB 5783072 A GB5783072 A GB 5783072A GB 1405767 A GB1405767 A GB 1405767A
Authority
GB
United Kingdom
Prior art keywords
group
plasma lipid
lipid levels
pharmaceutical composition
reducing plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5783072A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethyl Corp
Original Assignee
Ethyl Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethyl Corp filed Critical Ethyl Corp
Priority to GB5783072A priority Critical patent/GB1405767A/en
Publication of GB1405767A publication Critical patent/GB1405767A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

1405767 Plasma lipid-reducing medicines ETHYL CORP 14 Dec 1972 57830/72 Heading A5B Compositions for reducing plasma lipid levels comprise a carrier and a compound: wherein each R is the same or different and is an alkyl, cycloalkyl, aryl or aralkyl group, R 1 and R 2 . are each hydrogen or a group as defined for R or they form, together with the C atom a C=S group, R 3 and R 4 are each hydro-. gen or a group as defined for R or, together with the N atom, they form a pyridine, piperidine, piperazine or morpholine group, "a" is from 0 to 4 and "b" and "e" are the same or different and are each 0 or 1. The compositions may be in conventional forms for oral and parenteral administration and may contain the usual carriers and excipients. The active compounds may be used in the form of salts.
GB5783072A 1972-12-14 1972-12-14 Method formulation and pharmaceutical composition for reducing plasma lipid levels Expired GB1405767A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB5783072A GB1405767A (en) 1972-12-14 1972-12-14 Method formulation and pharmaceutical composition for reducing plasma lipid levels

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5783072A GB1405767A (en) 1972-12-14 1972-12-14 Method formulation and pharmaceutical composition for reducing plasma lipid levels

Publications (1)

Publication Number Publication Date
GB1405767A true GB1405767A (en) 1975-09-10

Family

ID=10480127

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5783072A Expired GB1405767A (en) 1972-12-14 1972-12-14 Method formulation and pharmaceutical composition for reducing plasma lipid levels

Country Status (1)

Country Link
GB (1) GB1405767A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4173652A (en) * 1976-12-18 1979-11-06 Akzona Incorporated Pharmaceutical hydroxamic acid compositions and uses thereof
US4448776A (en) * 1981-02-12 1984-05-15 Karl Bucher Method of using certain substituted aliphatic secondary amines or their salts for easing breathing
EP0404039A1 (en) * 1989-06-23 1990-12-27 Roche Diagnostics GmbH Pharmaceuticals containing di-tert.butylhydroxyphenyl-derivatives and new derivatives
EP0476846A3 (en) * 1990-08-27 1992-08-05 Eli Lilly And Company Method for treating imflammation, ischemia-induced cell damage and muscular dystrophy
US5280046A (en) * 1991-02-22 1994-01-18 The University Of Colorado Foundation, Inc. Method of treating type I diabetes
US5552439A (en) * 1990-08-27 1996-09-03 Eli Lilly And Company Method of treating inflammatory bowel disease

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4173652A (en) * 1976-12-18 1979-11-06 Akzona Incorporated Pharmaceutical hydroxamic acid compositions and uses thereof
US4448776A (en) * 1981-02-12 1984-05-15 Karl Bucher Method of using certain substituted aliphatic secondary amines or their salts for easing breathing
EP0404039A1 (en) * 1989-06-23 1990-12-27 Roche Diagnostics GmbH Pharmaceuticals containing di-tert.butylhydroxyphenyl-derivatives and new derivatives
EP0476846A3 (en) * 1990-08-27 1992-08-05 Eli Lilly And Company Method for treating imflammation, ischemia-induced cell damage and muscular dystrophy
US5281623A (en) * 1990-08-27 1994-01-25 Eli Lilly And Company Method for treating inflammation
US5393786A (en) * 1990-08-27 1995-02-28 Eli Lilly And Company Method for treating inflammation, ischemia-induced cell damage and muscular dystrophy
US5552439A (en) * 1990-08-27 1996-09-03 Eli Lilly And Company Method of treating inflammatory bowel disease
US5280046A (en) * 1991-02-22 1994-01-18 The University Of Colorado Foundation, Inc. Method of treating type I diabetes

Similar Documents

Publication Publication Date Title
GB1505305A (en) Benzcycloamide derivatives
GB1205957A (en) Pharmaceutical compositions comprising 1-pnenoxy-2-aminopropanes
GB1260848A (en) Propanolamine derivatives
GB1420411A (en) Pyridine compounds and process for their manufacture
NO175979C (en) Analogous Process for Preparation of Therapeutically Active Pteridines
GB1181673A (en) Derivatives of Xanthen and Thiaxanthen and Preparation Thereof
GB1405767A (en) Method formulation and pharmaceutical composition for reducing plasma lipid levels
GB1342520A (en) Alpha-alkyl-substituted benzyl or thenyl-benzyloxy derivatives of amines
GB1296544A (en)
GB1444396A (en) Succinic acid derivatives
GB1084150A (en)
GB1352257A (en) Pyridyltriazoles their preparation and compositions containing them
GB1519210A (en) Antiarrythmic compositions containing pyrrolidinyl derivatives
GB1530138A (en) Pharmaceutical composition
GB1246117A (en) Pharmaceutical preparations containing glucose compounds, glucose derivatives and process for their manufacture
GB1514225A (en) Paracetamol derivatives
GB1424432A (en) Pharmaceutical compositions
GB1156781A (en) New Heterocyclic Compounds
GB1448758A (en) Thiazole derivatives
GB1492622A (en) Aralkyl esters of amino alkanoic acids
GB1120186A (en) Cyclohexene amino acid derivatives and process for their preparation
ES8200347A1 (en) Pyridine derivatives, process for their preparation and medicaments containing them.
GB1423761A (en) Xylidides
GB1175617A (en) Substituted Pteridine Derivatives
GB1322640A (en) Selected 5-substituted-5-phenylalkyl barbituric acids analgetic compositions and method based thereon

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee